Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.42%1.67B | 23.43%1.73B | 5.63%6.25B | 1.84%1.79B | 4.37%1.54B | 3.97%1.52B | 14.56%1.4B | 29.44%5.92B | 32.59%1.76B | 34.00%1.48B |
| Cost of revenue | 18.52%1.34B | 29.45%1.41B | 6.83%4.67B | 2.88%1.32B | 2.97%1.13B | 8.38%1.13B | 14.93%1.09B | 28.77%4.37B | 38.84%1.28B | 34.48%1.1B |
| Gross profit | -13.25%335.54M | 2.70%324.81M | 2.26%1.59B | -0.96%475.76M | 8.48%406.41M | -7.06%386.77M | 13.33%316.28M | 31.38%1.55B | 18.42%480.36M | 32.61%374.65M |
| Operating expense | 33.14%106.63M | 41.49%114.75M | 20.64%426.24M | 418.98%193.31M | 12.05%94.94M | -28.04%80.08M | 8.78%81.1M | 22.24%353.31M | -73.24%37.25M | 56.47%84.73M |
| Selling and administrative expenses | 5.50%135.49M | 16.97%129.12M | 8.72%528.09M | 9.08%162.87M | 14.79%126.4M | -1.16%128.43M | 14.57%110.39M | 26.56%485.71M | 19.64%149.31M | 22.55%110.11M |
| -Selling and marketing expense | 36.39%20.8M | 13.84%18.63M | -16.39%49.33M | -72.67%6.72M | 18.04%11M | -9.31%15.25M | 97.38%16.36M | -7.29%59M | -3.80%24.58M | -35.25%9.32M |
| -General and administrative expense | 1.34%114.69M | 17.52%110.5M | 12.20%478.76M | 25.19%156.16M | 14.49%115.4M | 0.05%113.18M | 6.77%94.03M | 33.29%426.71M | 25.67%124.74M | 33.57%100.79M |
| Other operating expenses | 83.51%17.95M | -23.56%24.69M | -31.89%127.52M | -22.66%100.33M | -33.16%18.29M | -71.34%9.78M | 35.22%32.3M | 33.57%187.22M | 65.25%129.73M | 44.57%27.36M |
| Total other operating income | -19.46%46.81M | -36.57%39.06M | -28.24%229.37M | -71.10%69.89M | -5.67%49.75M | 10.13%58.13M | 34.81%61.59M | 36.06%319.63M | 277.01%241.79M | -3.45%52.74M |
| Operating profit | -25.36%228.92M | -10.68%210.06M | -3.17%1.16B | -36.26%282.45M | 7.43%311.47M | 0.60%306.69M | 14.98%235.17M | 34.35%1.2B | 66.29%443.12M | 26.95%289.92M |
| Net non-operating interest income (expenses) | 13.54%-62.34M | 5.11%-72.73M | 7.81%-283.15M | 6.21%-70.15M | 25.21%-64.25M | 6.65%-72.1M | -10.79%-76.65M | -20.18%-307.14M | 10.70%-74.8M | -38.66%-85.92M |
| Non-operating interest expense | -13.54%62.34M | -5.11%72.73M | -7.81%283.15M | -6.21%70.15M | -25.21%64.25M | -6.65%72.1M | 10.79%76.65M | 20.18%307.14M | -10.70%74.8M | 38.66%85.92M |
| Net investment income | 12.97%-59.61M | 1,323.24%17.21M | -238.75%-42.13M | 838.80%31.23M | -116.98%-3.45M | -95.93%-68.5M | -103.38%-1.41M | 30.36M | 3.33M | 700.62%20.34M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 199.55%13.82M | 54.53%-1.82M | -1,219.00%-19.44M | 385.68%13.85M | -916.85%-15.41M | -746.52%-13.88M | -227.70%-3.99M | 34.92%-1.47M | -117.42%-4.85M | 112.35%1.89M |
| Special income (charges) | -186.12%-65.32M | 150.55%75.85M | ||||||||
| Less:Write off | ---- | ---- | 186.12%65.32M | ---- | ---- | ---- | ---- | -150.55%-75.85M | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -20.64%120.79M | -0.26%152.73M | -17.95%791.06M | -29.83%257.38M | 0.93%228.35M | -20.32%152.21M | -14.99%153.13M | 99.61%964.17M | 136.26%366.8M | 53.12%226.23M |
| Income tax | -12.18%56.57M | -3.14%45.06M | 8.30%323.8M | 233.83%125.36M | -25.58%87.5M | -18.03%64.42M | -28.71%46.52M | 10.15%298.98M | -69.88%37.55M | 100.11%117.57M |
| Net income | -26.86%64.21M | 1.00%107.67M | -29.76%467.26M | -59.90%132.02M | 29.62%140.85M | -21.91%87.79M | -7.19%106.6M | 214.37%665.19M | 976.57%329.25M | 22.10%108.66M |
| Net income continuous operations | -26.86%64.21M | 1.00%107.67M | -29.76%467.26M | -59.90%132.02M | 29.62%140.85M | -21.91%87.79M | -7.19%106.6M | 214.37%665.19M | 976.57%329.25M | 22.10%108.66M |
| Noncontrolling interests | -827.49%-13.36M | -94.48%448K | -23.73%13.9M | -197.59%-11.82M | 549.70%15.77M | -73.57%1.84M | 204.92%8.11M | 169.27%18.22M | 406.86%12.12M | -241.93%-3.51M |
| Net income attributable to the company | -9.75%77.58M | 8.86%107.22M | -29.93%453.37M | -54.64%143.85M | 11.51%125.08M | -18.51%85.95M | -12.22%98.49M | 215.86%646.97M | 818.40%317.13M | 29.64%112.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0.46%11.79M | 0.02%11.61M | 7.05%49.99M | 28.27%14.9M | 0.03%11.74M | -0.42%11.74M | 0.48%11.61M | 0.30%46.7M | 1.14%11.61M | 0.03%11.74M |
| Net income attributable to common stockholders | -11.36%65.78M | 10.04%95.6M | -32.80%403.38M | -57.79%128.95M | 12.85%113.34M | -20.79%74.21M | -13.68%86.88M | 279.26%600.28M | 1,225.47%305.52M | 34.28%100.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -11.32%0.0188 | 10.08%0.0273 | -32.79%0.115 | -57.75%0.0368 | 12.94%0.0323 | -20.60%0.0212 | -13.59%0.0248 | 281.07%0.1711 | 1,240.00%0.0871 | 34.27%0.0286 |
| Diluted earnings per share | -11.32%0.0188 | 10.08%0.0273 | -32.79%0.115 | -57.75%0.0368 | 12.94%0.0323 | -20.60%0.0212 | -13.59%0.0248 | 281.07%0.1711 | 1,240.00%0.0871 | 34.27%0.0286 |
| Dividend per share | 0 | 0.00%0.05 | 16.67%0.07 | 0 | 0.00%0.02 | 0 | 25.00%0.05 | 0.00%0.06 | 0 | 0.00%0.02 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.